365 related articles for article (PubMed ID: 28590242)
1. Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
Naguib MM; Grund C; Arafa AS; Abdelwhab EM; Beer M; Harder TC
J Gen Virol; 2017 Jun; 98(6):1169-1173. PubMed ID: 28590242
[TBL] [Abstract][Full Text] [Related]
2. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
[TBL] [Abstract][Full Text] [Related]
3. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
4. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
[TBL] [Abstract][Full Text] [Related]
5. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
[TBL] [Abstract][Full Text] [Related]
6. Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets.
Naguib MM; Ulrich R; Kasbohm E; Eng CLP; Hoffmann D; Grund C; Beer M; Harder TC
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931674
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
8. Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens.
Dash SK; Kumar M; Kataria JM; Nagarajan S; Tosh C; Murugkar HV; Kulkarni DD
Microb Pathog; 2016 Jun; 95():157-165. PubMed ID: 27057675
[TBL] [Abstract][Full Text] [Related]
9. Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.
Gomaa MR; Khalil AA; Kandeil A; Sabir JSM; Kayed A; Moatasim Y; El Saied MF; El-Safty MM; Kayali G; Ali MA
Poult Sci; 2019 Dec; 98(12):6289-6295. PubMed ID: 31265106
[TBL] [Abstract][Full Text] [Related]
10. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
11. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
12. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.
Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Safwat M; Nawar AA; Erfan AM; Hassan MK; Aly MM; Hafez HM
Vet Microbiol; 2011 May; 150(1-2):28-34. PubMed ID: 21236607
[TBL] [Abstract][Full Text] [Related]
14. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
[TBL] [Abstract][Full Text] [Related]
15. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
[TBL] [Abstract][Full Text] [Related]
16. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
[TBL] [Abstract][Full Text] [Related]
18. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
[TBL] [Abstract][Full Text] [Related]
20. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
